Brief: Neurizon Files Ind Application To Support Healey Als Platform Trial
18/12/2024 12:38
Dec 18 (Reuters) - Neurizon Therapeutics Ltd NUZ.AX :
* NEURIZON FILES IND APPLICATION TO SUPPORT HEALEY ALS
PLATFORM
TRIAL
Source text: ID:nPnbYcrBsa
Further company coverage: NUZ.AX
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon Therapeutics jumps on deal with US firm
Brief: Neurizon Therapeutics Executes Long-Term Supply Agreement With Elanco
Brief: Neurizon Therapeutics Receives Ethics Approval For Phase 1 Nuz-001 Oral Liquid Formulation Study
Brief: Neurizon Therapeutics Announces Placement Of Entitlement Offer Shortfall To Raise ~A$2.7 Million
Brief: Neurizon Therapeutics Says Michael Thurn Resigns As Managing Director And CEO